– A technology-based company for the development of graphene-based applications for neurological diseases, and founded by researchers from IMB-CNM-CSIC, ICN2 and ICREA, who lead some of the research areas of the Graphene Flagship. – The agreement paves the way for
A study published in Nature Nanotechnology shows that flexible brain probes made of graphene micro-transistors can be used to record pathological brain signals associated with epilepsy with excellent fidelity and high spatial resolution. This research was led by the Institute of
Doctor Miguel Zea, defended his PhD thesis titled «Inkjet printing technology is driving the innovation of sensors for point-of-care devices» on Friday, 23July 2021 in a mixed in person/online session at the UAB Sala de Graus. The PhD thesis was
Doctor Eduard Masvidal, defended his PhD thesis titled Graphene microtransistors: a wide-bandwidth technology for recording brain field potentials» on Monday, 12 July 2021 in a mixed in person/online session at the ICN2 seminar room. The PhD thesis was supervised by
Two reviews from our group summarise the latest efforts in organ-on-chip technologies to emulate in vitro microfluidic systems. These devices are an opportunity to evolve the fields of biofabrication and sensing technology Organ-on-chip (OOC) technology has been an efficient tool
We are placed at the Barcelona Microelectronics Institute (IMB-CNM, CSIC) and we also belong to the CIBER-BBN. The group takes advantage of the technological capacities available at the Clean Room of the IMB-CNM in order to provide novel solutions to different biomedical applications. These solutions are mainly based on sensing solutions at different levels of biological organization, i.e. mollecules, cells and organs. As a consequence, the group works jointly with different biomedical research groups, from the theoretical analysis to the final clinical trials.